Oxford Nanopore integrates “Remora”: a tool to enable real-time, high-accuracy epigenetic insights with nanopore sequencing software MinKNOW Oxford Nanopore has today released Remora, a high-performance tool for methylation analysis, into its operating software, MinKNOW, broadening access to direct, PCR-free nanopore sequencing that captures methylation across the whole genome OXFORD, UK — From today, Oxford Nanopore users have easy […]

CINCINNATI — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that its inhibitor-tolerant qPCR master mixes are ideal for the development of fast, accurate and highly sensitive qPCR monkeypox virus (monkeypox) molecular diagnostic tests. The recent outbreak of monkeypox has caused global concern due to its unprecedented […]

System Offers Consistent, Precise and Accessible Quantitative PCR Analysis for Singleplex and Duplex Assays HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX Duet Real-Time PCR System to support researchers in developing singleplex and duplex quantitative […]

Bio-Techne is extending ACD’s leadership in the spatial biology market by passing a milestone of offering 40,000 custom probes in over four hundred species MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced Advanced Cell Diagnostics (ACD), a brand of Bio-Techne, reached an extraordinary milestone of developing over 40,000 unique RNAscope in situ Hybridization (ISH) probes in over 400 […]

Financing Led by Medical Excellence Capital and Alexandria Venture Investments Gregory T. Lucier joins Pleno as Chairman of the Board of Directors SAN DIEGO — Pleno Inc., a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research, announced the close of $15 million in Pre-Series A financing led by experienced life […]

Addition of Aalto Bio Reagents expands Biosynth Carbosynth’s offer to its clinical diagnostics customers. Staad – Biosynth Carbosynth (“Biosynth”), a supplier of critical materials to the life science industry, announces today the acquisition of Aalto Bio Reagents (“Aalto”), a leading developer and provider of biological materials to the in-vitro diagnostic (IVD) and vaccine development industry in […]

DOD to fund planned manufacturing expansion and to prepare the U.S. for a rapid response to the next pandemic as part of Industrial Base Expansion SAN DIEGO — TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ: MRVI), and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, today announced […]

First companion diagnostic claim for Illumina’s TruSight™ Oncology Comprehensive (EU) test enables targeted therapy with Bayer’s VITRAKVI® (larotrectinib) for patients with NTRK fusion cancer SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro diagnostic TruSight™ Oncology (TSO) Comprehensive (EU) […]

FOSTER CITY, Calif. — Illumina Ventures, today announced the promotion of Malek Faham, MD, PhD, to Chief Scientist having previously served as both a Venture Partner and Entrepreneur in Residence (EIR). In addition, Charles Lin, PhD, has joined the team as a Principal, and Dave Johnson, PhD, has joined as an Entrepreneur in Residence. “Having […]